Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Sally Beauty Holdings
SBH
$1.46B
| $187K | ﹤0.01% |
14,949
-14,949
| -50% | -$184K |
|
2202
3D Systems Corp
DDD
$441M
| $187K | ﹤0.01% |
25,229
-25,231
| -50% | -$221K |
|
|
SI
2203
DELISTED
Silvergate Capital Corporation
SI
| $184K | ﹤0.01% |
10,564
-12,372
| -54% | -$491K |
|
|
MRC
2204
DELISTED
MRC Global
MRC
| $184K | ﹤0.01% |
15,857
-15,857
| -50% | -$167K |
|
|
DCT
2205
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $183K | ﹤0.01% |
15,200
-15,202
| -50% | -$174K |
|
2206
FuelCell Energy
FCEL
$1.89B
| $182K | ﹤0.01% |
2,194
-2,195
| -50% | -$212K |
|
2207
Warby Parker
WRBY
$3.19B
| $182K | ﹤0.01% |
13,504
-13,506
| -50% | -$207K |
|
2208
Wolverine World Wide
WWW
$1.64B
| $182K | ﹤0.01% |
16,653
-16,655
| -50% | -$221K |
|
2209
Healthcare Services Group
HCSG
$1.58B
| $182K | ﹤0.01% |
15,171
-15,169
| -50% | -$200K |
|
|
LBAI
2210
DELISTED
Lakeland Bancorp Inc
LBAI
| $182K | ﹤0.01% |
10,324
-10,324
| -50% | -$184K |
|
2211
Globalstar
GSAT
$10.3B
| $181K | ﹤0.01% |
9,117
-9,116
| -50% | -$240K |
|
2212
Gray Television
GTN
$417M
| $181K | ﹤0.01% |
16,156
-16,158
| -50% | -$200K |
|
2213
ADMA Biologics
ADMA
$2.01B
| $180K | ﹤0.01% |
+46,487
| New | +$143K |
|
|
DCH
2214
Dauch Corp
DCH
$1.39B
| $180K | ﹤0.01% |
22,992
-22,994
| -50% | -$206K |
|
2215
JELD-WEN Holding
JELD
$117M
| $179K | ﹤0.01% |
18,554
-18,554
| -50% | -$180K |
|
2216
Estrella Immunopharma
ESLA
$31M
| $178K | ﹤0.01% |
17,335
-17,335
| -50% | -$176K |
|
|
ARR
2217
Armour Residential REIT
ARR
$2.33B
| $178K | ﹤0.01% |
6,315
+2,206
| +54% | +$60.2K |
|
2218
Cinemark Holdings
CNK
$4.19B
| $177K | ﹤0.01% |
20,455
-20,457
| -50% | -$231K |
|
|
MNTV
2219
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $174K | ﹤0.01% |
24,904
-24,904
| -50% | -$180K |
|
2220
Vertex
VERX
$2.04B
| $173K | ﹤0.01% |
+11,897
| New | +$190K |
|
|
CDMO
2221
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $170K | ﹤0.01% |
12,362
-12,362
| -50% | -$189K |
|
2222
Cytek Biosciences
CTKB
$557M
| $170K | ﹤0.01% |
16,645
-16,647
| -50% | -$224K |
|
2223
GrafTech
EAF
$169M
| $169K | ﹤0.01% |
3,543
-3,543
| -50% | -$172K |
|
2224
NatWest
NWG
$73.7B
| $168K | ﹤0.01% |
26,025
-26,025
| -50% | -$152K |
|
2225
Coeur Mining
CDE
$15.9B
| $166K | ﹤0.01% |
49,561
-49,571
| -50% | -$176K |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.